RLYP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RLYP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Relypsa's change in inventory for the quarter that ended in Jun. 2016 was $-7.01 Mil. It means Relypsa's inventory increased by $7.01 Mil from Mar. 2016 to Jun. 2016 .
Relypsa's change in inventory for the fiscal year that ended in Dec. 2015 was $-8.85 Mil. It means Relypsa's inventory increased by $8.85 Mil from Dec. 2014 to Dec. 2015 .
Relypsa's Total Inventories for the quarter that ended in Jun. 2016 was $31.88 Mil.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Relypsa's Days Inventory for the quarter that ended in Jun. 2016 was 10,114.85.
Inventory Turnover measures how fast the company turns over its inventory within a year. Relypsa's Inventory Turnover for the quarter that ended in Jun. 2016 was 0.01.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Relypsa's Inventory-to-Revenue for the quarter that ended in Jun. 2016 was 5.44.
The historical data trend for Relypsa's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Relypsa Annual Data | |||||||||||
Trend | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | ||||||
Change In Inventory | - | - | - | - | -8.85 |
Relypsa Quarterly Data | |||||||||||||||||
Dec11 | Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | |
Change In Inventory | Get a 7-Day Free Trial | - | - | - | -16.02 | -7.01 |
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Relypsa (NAS:RLYP) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Relypsa's Days Inventory for the quarter that ended in is calculated as:
Days Inventory | = | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period |
= | 28.377 | / | 0.256 | * | 365 / 4 | |
= | 10,114.85 |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
Relypsa's Inventory Turnover for the quarter that ended in Jun. 2016 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 0.256 | / | 28.377 | |
= | 0.01 |
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Relypsa's Inventory to Revenue for the quarter that ended in Jun. 2016 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 28.377 | / | 5.221 | |
= | 5.44 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Relypsa's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Ronald A. Krasnow | officer: See Remarks | C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063 |
Kristine M Ball | officer: Chief Financial Officer & SVP | C/O RELYPSA, INC., 700 SAGINAW DRIVE, REDWOOD CITY CA 94063 |
Mcgirr David W J | director | 33 PHEASANT LANE, GREENWICH CT 06830 |
Paul J Hastings | director | 61 HARTFORD STREET, SAN FRANCISCO CA 94114 |
John A Orwin | director, officer: President & CEO | C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063 |
Kenneth J. Hillan | director | C/O ACHAOGEN, INC., 7000 SHORELINE COURT, SUITE 371, SOUTH SAN FRANCISCO CA 94080 |
Wilhelm Stahl | officer: SVP, Chief Technology Officer | C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063 |
J. Scott Garland | officer: SVP & Chief Commercial Officer | 210 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080 |
Daniel K Spiegelman | director | MYRIAD GENETICS, 320 WAKARA WAY, SALT LAKE CITY UT 84003 |
John P. Butler | director | C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063 |
Helen Torley | director | C/O ONYX PHARMACEUTICALS, INC., 249 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080 |
James D Dondero | 10 percent owner | 300 CRESCENT COURT, SUITE 700, DALLAS TX 75201 |
Orbimed Advisors Llc | 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
Samuel D Isaly | 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
Orbimed Capital Gp Iv Llc | 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
From GuruFocus
By Tiziano Frateschi Tiziano Frateschi • 10-26-2015
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.